Fundz

Reaction Biology Announces Closing Of Growth Investment From Cobepa And Chief Executive Officer Transition

PRIVATEMar 16, 2022

Round Type

Venture

Media And EntertainmentCommunity And LifestyleHealth Care

Description

Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a significant investment from Cobepa, an international private equity firm, to fuel the Company's continued growth and service line expansion.

Quick answer

Reaction Biology raised an undisclosed amount in a funding round, dated March 16, 2022.

How much did Reaction Biology raise?
Reaction Biology raised an undisclosed amount in a funding round on March 16, 2022.
What does Reaction Biology do?
Founded in 2001, Reaction is a contract research organization (CRO) that provides a full suite of drug discovery services to over 1,800 biopharmaceutical customers worldwide.

Source: Fundz verified event record.

Who to call at Reaction Biology, and when

A new round usually means Reaction Biology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Reaction Biology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Reaction Biology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Reaction Biology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Reaction Biology

About

Founded in 2001, Reaction is a contract research organization (CRO) that provides a full suite of drug discovery services to over 1,800 biopharmaceutical customers worldwide. Reaction's capabilities include functional biochemical assays, compound screening, a wide range of mechanistic and biophysical studies, and an extensive array of cell-based assays. Reaction maintains one of the largest panels of kinase assays in the world with over 750 unique assays. The Company performs over 5,000 client projects annually with its over 2,000 validated assays. The Company has lab facilities in Malvern, PA, and Freiburg, Germany, with approximately 130 employees.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Reaction Biology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Reaction Biology's next move

See what Strategic adds

Reaction Biology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.